Kiadis Pharma (KIADF) Short Interest Ratio & Short Volume

Short interest is the volume of Kiadis Pharma shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 100 shares of KIADF short. Learn More on Kiadis Pharma's current short interest.

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.55 billion), Block, Inc. ($7.47 billion), S&P Global Inc. ($7.40 billion), Analog Devices, Inc. ($6.82 billion), Aon plc ($5.98 billion), Charter Communications, Inc. ($5.10 billion), Wayfair Inc. ($4.38 billion), AMC Entertainment Holdings, Inc. ($2.87 billion), Teladoc Health, Inc. ($2.55 billion), and Nuance Communications, Inc. ($2.41 billion). View all of the most shorted stocks.

Short selling KIADF is an investing strategy that aims to generate trading profit from Kiadis Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Kiadis Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KIADF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KIADF, twice per month. The most recent reporting period available is July, 15 2021.